1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of neurological disorder
5.1.1.2. Rising awareness regarding Alzheimer's treatment
5.1.1.3. Availability of cost-effective medicine for the treatment of Alzheimer
5.1.2. Restraints
5.1.2.1. High cost of R&D activities for drug development
5.1.3. Opportunities
5.1.3.1. Advances in the treatment of Alzheimer's diseases
5.1.3.2. Adoption of online pharmacies and advantages offered by online channels
5.1.4. Challenges
5.1.4.1. Side effect associated with Alzheimer's drugs
5.2. Cumulative Impact of COVID-19

6. Alzheimer's Disease Drugs Market, by Drug Class
6.1. Introduction
6.2. Cholinergic
6.3. Combined Drug
6.4. Memantine

7. Alzheimer's Disease Drugs Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacy
7.3. Online Pharmacy
7.4. Retail Pharmacy

8. Americas Alzheimer's Disease Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Alzheimer's Disease Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Alzheimer's Disease Drugs Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. AB Science
12.2. AbbVie, Inc
12.3. AC Immune SA
12.4. Amgen Inc.
12.5. Amneal Pharmaceuticals
12.6. Avanir Pharmaceuticals Inc.
12.7. Axsome Therapeutics, Inc.
12.8. AZ Therapies, Inc
12.9. BioArctic Neuroscience
12.10. Biogen, Inc
12.11. Biohaven Pharmaceuticals, Inc
12.12. Cortexyme
12.13. Eli Lilly and Company
12.14. F. Hoffmann-La Roche AG
12.15. GE Healthcare
12.16. Genentech, Inc.
12.17. Green Valley Pharmaceuticals
12.18. Grifols, S.A.
12.19. H. Lundbeck A/S
12.20. Janssen Pharmaceutica
12.21. Lupin Limited
12.22. Merz Holding GmbH & Co KG
12.23. Mylan N.V.
12.24. Novartis AG
12.25. Otsuka Pharmaceutical Co., Ltd
12.26. Pfizer Inc.
12.27. Sun Pharmaceutical Industries Limited
12.28. Teva Pharmaceutical Industries Ltd.
12.29. The Takeda Pharmaceutical Company Limited
12.30. vTv Therapeutics Inc

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2027 (%)
FIGURE 4. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY DRUG CLASS, 2027
FIGURE 6. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY CHOLINERGIC, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY CHOLINERGIC, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY COMBINED DRUG, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY COMBINED DRUG, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY MEMANTINE, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY MEMANTINE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (%)
FIGURE 13. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 15. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 21. AMERICAS ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 22. ARGENTINA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 23. BRAZIL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 24. CANADA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 25. MEXICO ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 27. ASIA-PACIFIC ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 28. AUSTRALIA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 29. CHINA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 30. INDIA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. INDONESIA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. JAPAN ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. MALAYSIA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. PHILIPPINES ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. SINGAPORE ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. SOUTH KOREA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. TAIWAN ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. THAILAND ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. FRANCE ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. GERMANY ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. ITALY ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. NETHERLANDS ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. QATAR ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. RUSSIA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. SAUDI ARABIA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. SOUTH AFRICA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. SPAIN ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. UNITED ARAB EMIRATES ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. UNITED KINGDOM ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 52. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 53. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY CHOLINERGIC, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY COMBINED DRUG, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY MEMANTINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. AMERICAS ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 12. ARGENTINA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 13. BRAZIL ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 14. CANADA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 15. MEXICO ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 18. AUSTRALIA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 19. CHINA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 20. INDIA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 21. INDONESIA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. JAPAN ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. MALAYSIA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. PHILIPPINES ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. SINGAPORE ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. SOUTH KOREA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. TAIWAN ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. THAILAND ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. FRANCE ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. GERMANY ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. ITALY ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. NETHERLANDS ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. QATAR ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. RUSSIA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. SAUDI ARABIA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. SOUTH AFRICA ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. SPAIN ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. UNITED ARAB EMIRATES ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. UNITED KINGDOM ALZHEIMER'S DISEASE DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: SCORES
TABLE 42. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: BUSINESS STRATEGY
TABLE 43. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: PRODUCT SATISFACTION
TABLE 44. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: RANKING
TABLE 45. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 46. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: MERGER & ACQUISITION
TABLE 47. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 48. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 49. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: INVESTMENT & FUNDING
TABLE 50. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 51. GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

AB Science
AbbVie, Inc
AC Immune SA
Amgen Inc.
Amneal Pharmaceuticals
Avanir Pharmaceuticals Inc.
Axsome Therapeutics, Inc.
AZ Therapies, Inc
BioArctic Neuroscience
Biogen, Inc
Biohaven Pharmaceuticals, Inc
Cortexyme
Eli Lilly and Company
F. Hoffmann-La Roche AG
GE Healthcare
Genentech, Inc.
Green Valley Pharmaceuticals
Grifols, S.A.
H. Lundbeck A/S
Janssen Pharmaceutica
Lupin Limited
Merz Holding GmbH & Co KG
Mylan N.V.
Novartis AG
Otsuka Pharmaceutical Co., Ltd
Pfizer Inc.
Sun Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd.
The Takeda Pharmaceutical Company Limited
vTv Therapeutics Inc